HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling

Journal of Leukocyte Biology

Volumn 74, Issue 6, 2003, Pages 1117-1124

  Masci, Anna Maria ^a   Galgani, Mario ^a   Cassano, Silvana ^b   De Simone, Salvatore ^b   Gallo, Adriana ^b   De Rosa, Veronica ^a   Zappacosta, Serafino ^a   Racioppi, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Ctro Endocrinol ed Oncol S   (Italy)

Author keywords

cAMP; CREB; CXCR4; HIVenv

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOPROTEIN GP 120; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE LCK; STROMAL CELL DERIVED FACTOR 1ALPHA;

ARTICLE; CELL MEMBRANE PERMEABILITY; CLONAL ANERGY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; MONOCYTE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS ENVELOPE;

CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CLONAL ANERGY; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DENDRITIC CELLS; ENZYME INHIBITORS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; ISOQUINOLINES; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MONOCYTES; SULFONAMIDES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0348047538     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0503239     Document Type: Article

References (54)

1. Miedema, F., Petit, A. J., Terpstra, F. G., Schattenkerk, J. K., de Wolf, F., Al, B. J., Roos, M., Lange, J. M., Danner, S. A., Goudsmit, J. (1988) Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men: HIV affects the immune system before CD4+ T helper cell depletion occurs. J. Clin. Invest. 82, 1908-1914.
2. Clerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Lucey, D. R., Via, C. S., Shearer, G. M. (1989) Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-sero-positive patients. J. Clin. Invest. 84, 1892-1899.
3. Gurley, R. J., Ikeuchi, K., Byrn, R. A., Anderson, K., Groopman, J. E. (1989) CD4+ lymphocyte function with early human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 86, 1993-1997.
4. Musey, L. K., Krieger, J. N., Hughes, J. P., Schacker, T. W., Corer, L., McElrath, M. J. (1999) Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J. Infect. Dis. 180, 278-284.
5. Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell. S. L., Sax, P. E., Kalams, S. A., Walker, B. D. (1997) Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447-1450.
6. Roilides, E., Clerici, M., De Palma, L., Rubin, M., Pizzo, P. A., Shearer, G. M. (1991) Helper T-cell responses in children with human immunodeficiency virus type 1. J. Pediatr. 118, 724-730.
7. Groux, W., Torpier, G., Monte, D., Mouton, Y., Capron, A., Ameisen, J. C. (1992) Activation-induced death by apoptosis in CD4+ T cells from HIV-1 infected asymptomatic individuals. J. Exp. Med. 175, 331-340.
8. Meyaard, L., Otto, S. A., Joriker, H. R., Mijnster, M. J., Keet, R. P., Miedema, F. (1992) Programmed death of T cells in HIV-1 infection. Science 257, 217-219.
9. Geertsma, M. F., van Wengen-Stevenhagen, A., van Dam, E. M., Risberg, K., Kroon, F. P., Groeneveld, P. H., Nibbering, P. H. (1999) Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons. J. Infect. Dis. 180, 649-658.
10. Giovannetti, A., Pierdominici, M., Mazzetta, F., Mazzone, A. M., Ricci, G., Prozzo, A., Pandolfi, F., Paganelli, R., Aiuti, F. (2000) HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease Progression anti apoptosis, but not with anti-CD3-induced cell proliferation. AIDS Res. Hum. Retroviruses 16, 211-219.
11. Cayota, A., Vuillier, R., Gonzalez, G., Dighiero, G. (1996) CD4+ lymphocytes from HIV-infected patients display impaired CD45-associated tyrosine phosphatase activity which is enhanced by anti-oxidants. Clin. Exp. Immunol. 104, 11-17.
12. Guntermann, C., Amft, N., Murphy, B. J., Nye, K. E. (1998) Impaired CD45-associated tyrosine phosphatase activity during HIV-1 infection: implications for CD3 and CD4 receptor signalling. Biochem. Biophys. Res. Commun. 252, 69-77.
13. Guntermann, C., Dye, J., Nye, K. E. (1997) Human immunodeficiency virus infection abolishes CD4-dependent activation of ZAP-70 by inhibition of p56lck. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14, 204-212.
14. Goldman, F., Crabtree, J., Hollenback, C., Koretzky, G. (1997) Sequestration of p56 (lck) by gp120, a model for TCR desensitization. J. Immunol. 158, 2017-2024.
15. Stefanova, I., Saville, M. W., Peters, C., Cleghorn, F. R., Schwartz, D., Venzon, D. J., Weinhold, K. J., Jack, N., Bartholomew, C., Blattner, W. A., Yarchoan, R., Bolen, J. B., Horak, I. D. (1996) HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression. J. Clin. Invest. 98, 1290-1297.
16. Cayota, A., Vuillier, F., Siciliano, J., Dighiero, G. (1994) Defective protein tyrosine phosphorylation and altered levels of p59fyn and p56lck in CD4 T cells from HIV-1 infected patients. Int. Immunol 6, 611-621.
17. Oyaizu, N., Chirmule, N., Kalyanaraman, V. S., Hall, W. W., Paliwa, W., Shuster, M., Palriva, S. (1990) Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 87, 2379-2383.
18. Cefai, D., Debre, P., Kaezorek, M., Idziorek, T., Autran, B., Bismuth, G. (1990) Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. J. Clin. Invest. 86, 2117-2124.
19. Chirmule, N., Kalyanaranian, V. S., Oyaizu, N., Slade, H. B., Paliwa, S. (1990) Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus. Blood 75, 152-159.
20. Hubert, P., Bismuth, G., Korner, M., Debre, P. (1995) HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling. Eur. J. Immunol. 25, 1417-1425.
21. Morio, T., Chatila, T., Geha, R. S. (1997) HIV glycoprotein gp120 inhibits TCH-CD3-mediated activation of fyn and lck. Int. Immunol. 9, 53-64.
22. Goldman, F., Crabtree, J., Hollenback, C., Koretzky, G. (1997) Sequestration of p56(lck) by gp120, a model for TCH desensitization. J. Immunol. 158, 2017-2024.
23. Masci, A. M., Lago Paz, F. Borriello, A., Della Pietra, V., Stoiber, H., Matarese, G., Della Ragione, F., Zappacosta, S., Racioppi, L. (1999) Effects of exposure to inactivated human immunodeficiency virus type 1 of T-cell subset activation. Eur. J. Immunol. 29, 1879-1889.
24. Torgersen, K. M., Vang, T., Abralhamsen, H., Yaqub, S., Tasken, K. (2002) Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell. Signal. 14, 1-9.
25. Vaag, T., Torgersen, K. M., Sundvold, V., Saxena, M., Levy, F. O., Skalhegg, B. S., Hansson, V., Mustelin, T., Tasken, K. (2001) Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med. 193, 497-507.
26. Bodor, J., Bodorova, J., Gress, R. (2000) Suppression of T cell function: a potential role for transcriptional repressor ICER. J. Leukoc. Biol. 67, 774-799.
27. Tenbrock, K., Juang, Y-T., Tolnay, M., Tsokos, G. C. (2003) The cyclic adenosine 5-monosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J. Immunol. 170, 2971-2976.
28. Hofmann, B., Nishanian, P., Nguyen, T., Insixiengmay, P., Fahey, J. L. (1993) Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc. Natl. Acad. Sci. USA 90, 6676-6680.
29. Hofmann, B., Nishanian, P., Nguyen, T., Liu, M., Fahey, J. L. (1993) Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS 7, 659-664.
30. Aandahl, E. M., Aukrust, P., Skalbegg, B. S., Muller, F., Froland, S. S., Hansson, V., Tasken, K. (1998) Protein kinase A type 1 antagonist restores Immune responses of T Cells from HIV-infected patients. FASEB J. 12, 855-862.
31. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
32. Juszezak, R. J., Turchin, H., Trimeh, A., Culp, J., Kassis, S. (1991) Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with CD4 ia human T lymphocytes. J. Biol. Chem. 266, 11176-11183.
33. Cefai, D., Ferrer, M., Serpente, N., Idziorek, T., Dautry-Varsat, A., Debre, P., Bismuth, G. (1992) Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation. J. Immunol. 149, 285-294.
34. Banda, N. K., Bernier, J., Kurahara, D. K., Kurrle, R., Haigwood, N., Sekaly, R. P., Finkel, T. H. (1992) Crosslinking CD4 by human immonodeficiency virus gp 120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176, 1099-1106.
35. Tamma, S. M., Chirmule, N., McCloskey, T. W., Oyaizu, N., Kalyanaraman, V. S., Pahwa, S. (1997) Signals transduced through the CD4 molecule interfere with TCR/CD3-mediated ras activation leading to T cell anergy/apoptosis. Clin. Immunopathol. 85, 195-201.
36. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, W., Sodroski, J., Hendrickson, W. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and neutralizing human antibody. Nature 393, 648-659.
37. Popik, W., Pitha, P.M. (2000) Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. Virology 276, 1-6.
38. Fantuzzi, L., Canini, I., Belardelli, F., Gessani, S. (2001) HIV-1 gp120 stimulates the production of b-chemokines in human peripheral blood monocytes through a CD4-independent mechanism. J. Immunol. 166, 5381-5387.
39. Iyengar, U., Schwartz, D. H., Hildreth, J. E. K. (1999) T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis. J. Immunol. 162, 6263-6267.
40. Siliciano, R. F. (1996) The role of CD4 in HIV envelope-mediated pathogenesis. Curr. Top. Microbiol. Immunol. 205, 159-179.
41. Kinet, S., Bernard, F., Mongellaz, C., Perreau, M., Goldman, F. D., Taylor, N. (2002) gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4(+) lymphocytes. Blood 100, 2546-2553.
42. Kozak, S. L., Heard, J. M., Kabat, D. (2002) Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J. Virol. 76, 1802-1815.
43. Schade, A. E., Levine, A. D. (2002) Lipid raft heterogeneity in human peripheral blood T lymphoblasts: a mechanism for regulating the initiation of TCR signal transduction. J. Immunol. 168, 2233-2239.
44. Rodgers, W., Rose, J. K. (1996) Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains. J. Cell Biol. 135, 1515-1523.
45. Xavier, R., Brennan, T., Li, Q., McCormack, C., Seed, B. (1998) Membrane compartmentation is required for efficient T cell activation. Immunity 8, 723-773.
46. Chalasani, S. H., Baribaud, F., Coughlan, C. M., Sunshine, M. J., Lee, V. M., Doms, R. W., Littman, D. R., Raper, J. A. (2003) The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. J. Neurosci. 23, 4601-4612.
47. Damas, J. K., Waehre, T., Yndestad, A., Ueland, T., Muller, F., Eiken, H. G., Holm, A. M., Halvorsen, B., Froland, S. S., Gullestad, L., Aukrust, P. (2002) Stromal cell-derived factor-1 alpha in unstable angina: potential anti-inflammatory and matrix-stabilizing effects. Circulation 106, 36-42.
48. Suárez, A., Mozo, L., Gayo, A., Zamorano, J., Gutiérrez, C. (1997) Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand: involvement of transcriptional and posttranscriptional mechanisms. Eur. J. Immunol. 27, 2822-2830.
49. Zhang, F., Rincon, M., Flavell, R. A., Aune, T. M. (2000) Defective Th function induced by a dominant-negative cAMP response element binding protein mutation is reversed by Bcl-2. J. Immunol. 165, 1762-1767.
50. Snijdewint, F. G. M., Kalinski, P., Wierenga, E. A., Bos, J. D., Kapsenberg, L. (1993) Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150, 5321-5326.
51. Elenkov, I. J., Webster, E., Papanicolau, D. A., Fleisher, T. A., Chrousos, G. P., Wilder, R. L. (1998) Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 161, 2586-2592.
52. Kolenko, V., Rayman, P., Ray, B., Catheart, M. K., O'Shea, J., Tubbs, R., Rybicki, L., Bukowski, R., Finke, J. (1999) Downregulation of JACK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signalling pathway. Blood 93, 2308-2314.
53. Chen, C., Zhang, D., LaPorte, J. M., Ray, A. (2000) Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J. Immunol. 165, 5597-5602.
54. Suarez, A., Mozo, L., Gutierrez, C. (2002) Generation of CD4(+)D45RA(+) effector T cells by stimulation in the presence of cyclic adenosinc 5′-monophosphate-elevating agents. J. Immunol. 169, 1159-1167.